Literature DB >> 1330307

Clinical and pharmacokinetic effects of a diet rich in insoluble fiber on Parkinson disease.

R Astarloa1, M A Mena, V Sánchez, L de la Vega, J G de Yébenes.   

Abstract

In this study, the effects of a diet rich in insoluble fiber (DRIF) on motor disability and the peripheral pharmacokinetics of orally administered L-dopa in Parkinsonian patients with marked constipation are analyzed. We found a useful effect of a DRIF on plasma L-dopa concentration and motor function. The greatest effect on the plasma L-dopa levels was found early (at 30 and 60 min) after oral administration. There was a relationship between the improvement of constipation and the higher bioavailability of L-dopa. DRIF can be a coadjuvant treatment in patients with Parkinson's disease.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1330307     DOI: 10.1097/00002826-199210000-00004

Source DB:  PubMed          Journal:  Clin Neuropharmacol        ISSN: 0362-5664            Impact factor:   1.592


  22 in total

Review 1.  Food-drug interactions.

Authors:  Lars E Schmidt; Kim Dalhoff
Journal:  Drugs       Date:  2002       Impact factor: 9.546

2.  Neurotoxin-Induced Catecholaminergic Loss in the Colonic Myenteric Plexus of Rhesus Monkeys.

Authors:  Jeanette M Shultz; Henry Resnikoff; Viktorya Bondarenko; Valerie Joers; Andres Mejia; Heather Simmons; Marina E Emborg
Journal:  J Alzheimers Dis Parkinsonism       Date:  2016-11-03

Review 3.  Management of chronic constipation in adults.

Authors:  K Krogh; G Chiarioni; W Whitehead
Journal:  United European Gastroenterol J       Date:  2016-08-02       Impact factor: 4.623

Review 4.  Clinical pharmacokinetic and pharmacodynamic properties of drugs used in the treatment of Parkinson's disease.

Authors:  Dirk Deleu; Margaret G Northway; Yolande Hanssens
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

Review 5.  Effects of food on clinical pharmacokinetics.

Authors:  B N Singh
Journal:  Clin Pharmacokinet       Date:  1999-09       Impact factor: 6.447

6.  Protective effects of Althaea officinalis L. extract in 6-hydroxydopamine-induced hemi-Parkinsonism model: behavioral, biochemical and histochemical evidence.

Authors:  Maryam Rezaei; Masoud Alirezaei
Journal:  J Physiol Sci       Date:  2014-01-25       Impact factor: 2.781

Review 7.  [Gastrointestinal dysfunction in idiopathic Parkinson's disease].

Authors:  K Del Tredici; W H Jost
Journal:  Nervenarzt       Date:  2012-10       Impact factor: 1.214

Review 8.  Pharmacokinetic considerations in gastrointestinal motor disorders.

Authors:  G S Hebbard; W M Sun; F Bochner; M Horowitz
Journal:  Clin Pharmacokinet       Date:  1995-01       Impact factor: 6.447

Review 9.  Potential influences of complementary therapy on motor and non-motor complications in Parkinson's disease.

Authors:  Theresa A Zesiewicz; Marian L Evatt
Journal:  CNS Drugs       Date:  2009-10       Impact factor: 5.749

Review 10.  Bladder and bowel dysfunction in Parkinson's disease.

Authors:  R Sakakibara; T Uchiyama; T Yamanishi; K Shirai; T Hattori
Journal:  J Neural Transm (Vienna)       Date:  2008-03-10       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.